These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3003815

  • 1. Characterization of biological properties of synthetic and biological leukotriene B3.
    Evans J, Zamboni R, Nathaniel D, Leveillé C, Ford-Hutchinson AW.
    Prostaglandins; 1985 Dec; 30(6):981-8. PubMed ID: 3003815
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils.
    Prescott SM, Zimmerman GA, Seeger AR.
    Biochem Biophys Res Commun; 1984 Jul 31; 122(2):535-41. PubMed ID: 6087805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Leukotriene B formation by neutrophils from essential fatty acid-deficient rats.
    Stenson WF, Prescott SM, Sprecher H.
    J Biol Chem; 1984 Oct 10; 259(19):11784-9. PubMed ID: 6090446
    [Abstract] [Full Text] [Related]

  • 8. Leukotriene B4: biological activities and the cytoskeleton.
    Cunningham FM, Smith MJ.
    Br J Pharmacol; 1982 Feb 10; 75(2):383-7. PubMed ID: 6313109
    [Abstract] [Full Text] [Related]

  • 9. Biological properties of dihydro-leukotriene B4, an alternative leukotriene B4 metabolite.
    Kaever V, Damerau B, Wessel K, Resch K.
    FEBS Lett; 1988 Apr 25; 231(2):385-8. PubMed ID: 2834233
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils.
    Lee TH, Sethi T, Crea AE, Peters W, Arm JP, Horton CE, Walport MJ, Spur BW.
    Clin Sci (Lond); 1988 May 25; 74(5):467-75. PubMed ID: 2836122
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Leukotriene A5 is a substrate and an inhibitor of rat and human neutrophil LTA4 hydrolase.
    Nathaniel DJ, Evans JF, Leblanc Y, Léveillé C, Fitzsimmons BJ, Ford-Hutchinson AW.
    Biochem Biophys Res Commun; 1985 Sep 16; 131(2):827-35. PubMed ID: 2996528
    [Abstract] [Full Text] [Related]

  • 19. Leukotriene A4: preparation and enzymatic conversion in a cell-free system to leukotriene B4.
    Maycock AL, Anderson MS, DeSousa DM, Kuehl FA.
    J Biol Chem; 1982 Dec 10; 257(23):13911-4. PubMed ID: 6292215
    [Abstract] [Full Text] [Related]

  • 20. Activation of leukocyte movement and displacement of [3H]leukotriene B4 from leukocyte membrane preparations by (12R)- and (12S)-hydroxyeicosatetraenoic acid.
    Evans JF, Leblanc Y, Fitzsimmons BJ, Charleson S, Nathaniel D, Léveillé C.
    Biochim Biophys Acta; 1987 Feb 23; 917(3):406-10. PubMed ID: 3026490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.